Providence Medical Technology Gains FDA Clearance for DTRAX Spinal System

Providence Medical Technology received FDA 510(k) clearance to market its DTRAX® Spinal System for use in posterior cervical fusion in patients with degenerative disc disease. This 510(k) provides a more specific indication for DTRAX, which was a Class I device with a broad indication for fusion.

The DTRAX Spinal System is reportedly the only...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us